Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 712.17 Thousand EUR | -22.82% |
| 2022 | 922.68 Thousand EUR | 149.04% |
| 2021 | 370.5 Thousand EUR | -61.54% |
| 2020 | 963.28 Thousand EUR | -0.76% |
| 2019 | 970.63 Thousand EUR | -5.69% |
| 2018 | 1.02 Million EUR | -21.07% |
| 2017 | 1.3 Million EUR | -12.41% |
| 2016 | 1.48 Million EUR | -11.64% |
| 2015 | 1.68 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 52.75 Thousand EUR | 0.0% |
| 2024 Q1 | 52.75 Thousand EUR | -67.84% |
| 2023 Q1 | 192.08 Thousand EUR | -58.08% |
| 2023 Q3 | 164 Thousand EUR | -57.31% |
| 2023 Q4 | 164 Thousand EUR | 0.0% |
| 2023 Q2 | 384.17 Thousand EUR | 100.0% |
| 2023 FY | 712.17 Thousand EUR | -22.82% |
| 2022 Q2 | 464.44 Thousand EUR | 100.0% |
| 2022 Q4 | 458.24 Thousand EUR | 100.0% |
| 2022 FY | 922.68 Thousand EUR | 149.04% |
| 2022 Q1 | 232.22 Thousand EUR | -33.27% |
| 2022 Q3 | 229.12 Thousand EUR | -50.67% |
| 2021 Q1 | 11.25 Thousand EUR | -96.95% |
| 2021 FY | 370.5 Thousand EUR | -61.54% |
| 2021 Q4 | 348 Thousand EUR | 100.0% |
| 2021 Q3 | 174 Thousand EUR | 673.33% |
| 2021 Q2 | 22.5 Thousand EUR | 100.0% |
| 2020 Q4 | 368.62 Thousand EUR | 100.0% |
| 2020 Q3 | 184.31 Thousand EUR | -69.01% |
| 2020 Q1 | 297.32 Thousand EUR | -46.68% |
| 2020 Q2 | 594.65 Thousand EUR | 100.0% |
| 2020 FY | 963.28 Thousand EUR | -0.76% |
| 2019 FY | 970.63 Thousand EUR | -5.69% |
| 2019 Q4 | 557.61 Thousand EUR | 100.0% |
| 2019 Q3 | 278.8 Thousand EUR | -32.5% |
| 2019 Q2 | 413.02 Thousand EUR | 100.0% |
| 2019 Q1 | 206.51 Thousand EUR | -39.76% |
| 2018 Q4 | 342.8 Thousand EUR | 43.36% |
| 2018 Q2 | 223.62 Thousand EUR | -0.0% |
| 2018 FY | 1.02 Million EUR | -21.07% |
| 2018 Q1 | 223.63 Thousand EUR | -35.46% |
| 2018 Q3 | 239.11 Thousand EUR | 6.92% |
| 2017 Q4 | 346.5 Thousand EUR | 60.6% |
| 2017 Q3 | 215.76 Thousand EUR | 0.0% |
| 2017 FY | 1.3 Million EUR | -12.41% |
| 2016 FY | 1.48 Million EUR | -11.64% |
| 2015 FY | 1.68 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Affluent Medical SA | 1.22 Million EUR | 41.816% |
| Bluelinea Société Anonyme | 9826.00 EUR | -7147.842% |
| Carmat SA | 2.84 Million EUR | 74.994% |
| Diagnostic Medical Systems S.A. | 42.15 Million EUR | 98.311% |
| Euromedis Groupe | 37.42 Million EUR | 98.097% |
| Eurobio Scientific Société anonyme | 130.64 Million EUR | 99.455% |
| Ikonisys S.A. | 448.55 Thousand EUR | -58.77% |
| Implanet S.A. | 7.44 Million EUR | 90.437% |
| Median Technologies SA | 22.22 Million EUR | 96.796% |
| SpineGuard SA | 4.31 Million EUR | 83.487% |
| Theraclion SA | 1.82 Million EUR | 60.917% |
| Euroapi S.A. | 1.01 Billion EUR | 99.93% |
| Guerbet SA | 785.69 Million EUR | 99.909% |
| Ion Beam Applications SA | 428.71 Million EUR | 99.834% |
| Koninklijke Philips N.V. | 18.16 Billion EUR | 99.996% |